Erasca to Present at the Bank of America Securities Health Care Conference
Erasca (NASDAQ: ERAS), a clinical-stage precision oncology company focused on developing therapies for RAS/MAPK pathway-driven cancers, has announced its participation in the Bank of America Securities 2025 Health Care Conference. The event will take place at the Encore Hotel in Las Vegas, Nevada. The company's management will deliver a presentation on Wednesday, May 14, 2025, at 2:35 PM Pacific Time and will engage in one-on-one investor meetings. A live audio webcast will be accessible at Erasca.com/events, with a replay available for 30 days following the presentation.
Erasca (NASDAQ: ERAS), un'azienda di oncologia di precisione in fase clinica specializzata nello sviluppo di terapie per i tumori guidati dalla via RAS/MAPK, ha annunciato la sua partecipazione alla Bank of America Securities 2025 Health Care Conference. L'evento si svolgerà presso l'Hotel Encore a Las Vegas, Nevada. Il management dell'azienda terrà una presentazione il mercoledì 14 maggio 2025 alle 14:35 ora del Pacifico e parteciperà a incontri individuali con gli investitori. Una trasmissione audio in diretta sarà disponibile su Erasca.com/events, con una replica accessibile per 30 giorni dopo la presentazione.
Erasca (NASDAQ: ERAS), una compañía de oncología de precisión en etapa clínica enfocada en desarrollar terapias para cánceres impulsados por la vía RAS/MAPK, ha anunciado su participación en la Bank of America Securities 2025 Health Care Conference. El evento se llevará a cabo en el Hotel Encore en Las Vegas, Nevada. La dirección de la empresa realizará una presentación el miércoles 14 de mayo de 2025 a las 2:35 PM hora del Pacífico y participará en reuniones individuales con inversores. Una transmisión de audio en vivo estará disponible en Erasca.com/events, con una repetición accesible durante 30 días después de la presentación.
Erasca (NASDAQ: ERAS)는 RAS/MAPK 경로를 기반으로 하는 암 치료법 개발에 집중하는 임상 단계 정밀 종양학 회사로, Bank of America Securities 2025 Health Care Conference에 참여한다고 발표했습니다. 행사는 네바다주 라스베이거스의 앙코르 호텔에서 열릴 예정입니다. 회사 경영진은 2025년 5월 14일 수요일 오후 2시 35분(태평양 시간)에 발표를 진행하며, 1:1 투자자 미팅도 가질 예정입니다. 생중계 오디오 웹캐스트는 Erasca.com/events에서 시청 가능하며, 발표 후 30일간 다시보기 서비스도 제공됩니다.
Erasca (NASDAQ : ERAS), une société d'oncologie de précision en phase clinique axée sur le développement de thérapies pour les cancers liés à la voie RAS/MAPK, a annoncé sa participation à la Bank of America Securities 2025 Health Care Conference. L'événement se déroulera à l'hôtel Encore à Las Vegas, Nevada. La direction de l'entreprise présentera le mercredi 14 mai 2025 à 14h35, heure du Pacifique et participera à des réunions individuelles avec des investisseurs. Une diffusion audio en direct sera accessible sur Erasca.com/events, avec une rediffusion disponible pendant 30 jours après la présentation.
Erasca (NASDAQ: ERAS), ein klinisch fortgeschrittenes Präzisions-Onkologie-Unternehmen, das sich auf die Entwicklung von Therapien für RAS/MAPK-Signalweg-getriebene Krebsarten spezialisiert hat, hat seine Teilnahme an der Bank of America Securities 2025 Health Care Conference angekündigt. Die Veranstaltung findet im Encore Hotel in Las Vegas, Nevada, statt. Das Management des Unternehmens wird am Mittwoch, den 14. Mai 2025, um 14:35 Uhr Pazifischer Zeit eine Präsentation halten und Einzelgespräche mit Investoren führen. Ein Live-Audio-Webcast ist unter Erasca.com/events verfügbar, mit einer Wiedergabeoption für 30 Tage nach der Präsentation.
- None.
- None.
SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced its participation in the Bank of America Securities 2025 Health Care Conference being held at the Encore Hotel in Las Vegas, Nevada. Management will present on Wednesday, May 14, 2025, at 2:35 pm Pacific Time and will also participate in one-on-one investor meetings.
A live audio webcast of the event will be available online at Erasca.com/events. An archived replay of the event will be available for 30 days following the webcast at Erasca.com/events.
About Erasca
At Erasca, our name is our mission: To erase cancer. We are a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Our company was co-founded by leading pioneers in precision oncology and RAS targeting to create novel therapies and combination regimens designed to comprehensively shut down the RAS/MAPK pathway for the treatment of patients with cancer. We have assembled one of the deepest RAS/MAPK pathway-focused pipelines in the industry. We believe our team’s capabilities and experience, further guided by our scientific advisory board which includes the world’s leading experts in the RAS/MAPK pathway, uniquely position us to achieve our bold mission of erasing cancer.
Contact:
Joyce Allaire
LifeSci Advisors, LLC
jallaire@lifesciadvisors.com
Source: Erasca, Inc.
FAQ
When is Erasca (ERAS) presenting at the Bank of America Securities Health Care Conference 2025?
Where can I watch Erasca's (ERAS) presentation at the BofA Healthcare Conference?
What type of company is Erasca (ERAS)?
Will Erasca (ERAS) management be available for investor meetings at the BofA Healthcare Conference?
